NTN1 and bone cancer: In adult disease models, aberrant netrin-1: DCC signaling drives pathological nerve sprouting and pain: for example, in a rat bone cancer pain model, tumor-derived netrin-1 activates DCC to promote nociceptive neuron sprouting, and DCC inhibition attenuates hyperalgesia [15].